$96.07
-1.91% (Daily)
Market Cap
$8.10B
Revenue
$87.21M
Rank by MCap
#580
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Robert I. Blum
Headquarters
South San Francisco, CA
Employees
498
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
Loading chart…